COVID-19 Vaccine


Weekly COVID-19 Vaccine Graphic

COVID-19 Vaccine


COVID-19 Vaccine Locations

Localidades de Vacunas contra el COVID-19

The COVID-19 vaccine is available to anyone 12 years and older. Vaccines and medical care are available regardless of your immigration status.

Mobile COVID-19 Vaccination Clinics in Idaho

COVID DIRECTORY (ALL PAGES)


covid information sign up form   vaccine locations list

Related Pages: State Vaccine Data | State Vaccine Website | When you've been fully vaccinated

Region 4 (Ada, Boise, Elmore, & Valley) Vaccine Clinics

Information provided is inputted by vaccinating providers.


COVID-19 vaccine is only one of the ways to stop the spread of the disease. However, other health and safety measures such as wearing a mask, physical distancing, washing hands frequently, and staying home when sick continue to be important tools.


COVID-19 Vaccine FAQs

People with underlying medical conditions can receive the FDA-authorized COVID-19 vaccines provided they have not had an immediate or severe allergic reaction to a COVID-19 vaccine or to any of the ingredients in the vaccine.

Learn more about vaccination considerations for persons with underlying medical conditions. Vaccination is an important consideration for adults of any age with certain underlying medical conditions because they are at increased risk for severe illness from the virus that causes COVID-19.

Anyone 12 years and older is eligible to receive a COVID-19 vaccine. You can schedule a vaccine appointment at any of the COVID-19 Vaccine Locations listed here. *Those who are 12 to 17-years-old and wish to receive a COVID-19 vaccine may only receive the Pfizer vaccine because it is the only one currently authorized for these ages. The Moderna and Janssen (Johnson & Johnson) vaccines are authorized for use in those 18-years and older.

All the COVID-19 vaccines being used have gone through rigorous studies to ensure they are as safe as possible. Systems that allow CDC to watch for safety issues are in place across the entire country.

The U.S. Food and Drug Administration (FDA) has granted Emergency Use Authorizations for COVID-19 vaccines that have been shown to meet rigorous safety criteria and be effective as determined by data from the manufacturers and findings from large clinical trials. Watch a video describing the emergency use authorization.

Clinical trials for all vaccines must first show they meet rigorous criteria for safety and effectiveness before any vaccine, including COVID-19 vaccines, can be authorized or approved for use. The known and potential benefits of a COVID-19 vaccine must outweigh the known and potential risks of the vaccine. Learn more about how federal partners are ensuring the safety of COVID-19 vaccines in the United States.

Serious problems from vaccination can happen, but they are rare. CDC has learned of reports that some people have experienced severe allergic reactions—also known as anaphylaxis—after getting a COVID-19 vaccine. As an example, an allergic reaction is considered severe when a person needs to be treated with epinephrine or EpiPen© or if they must go to the hospital. Learn more about COVID-19 vaccines and allergies.

These are not new technologies. The vaccines are actually set up to give us immunity that is better than natural infection. We know the side effects of the natural infection. When we compare the risks to those at the frontlines that are being exposed to the virus and those in our community who are at high-risk for severe disease and death, those risks greatly overshadow the unknown risks of the vaccine.

Weigh the risk of contracting or spreading this potentially life-threatening disease to those who are vulnerable against the risks, side effects, safety and effectiveness of the vaccines offered.

Older age and underlying medical conditions including obesity, a compromised immune system, hypertension, COPD, diabetes, and heart disease increase the risk of severe illness from the virus and should be considered as well. You may wish to discuss with your primary care provider.

Vaccines currently in clinical trials in the United States won’t cause you to test positive on viral tests, which are used to see if you have a current infection.

If your body develops an immune response, which is the goal of vaccination, there is a possibility you may test positive on some antibody tests. Antibody tests indicate you had a previous infection and that you may have some level of protection against the virus. Experts are currently looking at how COVID-19 vaccination may affect antibody testing results.

Yes. Data from phase 2/3 clinical trials suggest that Pfizer-BioNTech COVID-19 vaccine is safe and likely efficacious in persons with evidence of a prior SARS-CoV-2 infection. Vaccination should be offered to persons regardless of history of prior symptomatic or asymptomatic SARS-CoV-2 infection.

At this time, experts do not know how long someone is protected from getting sick again after recovering from COVID-19. The immunity someone gains from having an infection, called natural immunity, varies from person to person. Some early evidence suggests natural immunity may not last very long.

There is currently no evidence that COVID-19 vaccination causes any problems with pregnancy, including the development of the placenta. In addition, there is no evidence that fertility problems are a side effect of any vaccine, including COVID-19 vaccines.

If you are trying to become pregnant now or want to get pregnant in the future, you may get a COVID-19 vaccine when one is available to you. Like all vaccines, scientists are studying COVID-19 vaccines carefully for side effects now and will continue to study them for many years. Learn more, HERE.

The Pfizer vaccine is not recommended for individuals under the age of 12 and the Moderna vaccine is not recommended for individuals under the age of 18.

There are currently no available data on the safety of COVID-19 vaccines, including Pfizer-BioNTech COVID-19 vaccine, in pregnant or lactating people. However, if pregnant or lactating people are part of a group that is recommended to receive a COVID-19 vaccine (e.g., healthcare personnel), they may choose to be vaccinated.

That is not recommended. If you receive the Pfizer vaccine for your first dose, then you need to receive the Pfizer vaccine for your second dose. This is the same for the Moderna vaccine.

People who are pregnant and part of a group recommended to receive the COVID-19 vaccine may choose to be vaccinated. If you have questions about getting vaccinated, talking with a healthcare provider may might help you make an informed decision. While breastfeeding is an important consideration, it is rarely a safety concern with vaccines.

No data are available yet on the safety of COVID-19 vaccines in lactating women or on the effects of mRNA vaccines on breastfed infants or on milk production/excretion. mRNA vaccines are not thought to be a risk to breastfeeding infants. People who are breastfeeding and are part of a group recommended to receive a COVID-19 vaccine, such as healthcare personnel, may choose to be vaccinated.

To make sure that more information is gathered regarding the safety of these vaccines when administered during pregnancy, pregnant people are encouraged to enroll in v-safe, CDC’s new smartphone-based tool being used to check-in on people’s health after they receive a COVID-19 vaccine. If pregnant people report health events through v-safe after vaccination, someone from CDC may call to check on them and get more information. Additionally, pregnant people enrolled in v-safe will be contacted by CDC and asked to participate in a pregnancy registry that will monitor them through pregnancy and the first 3 months of infancy.

The federal government oversees a centralized system to order, distribute, and track COVID-19 vaccines. All vaccines are ordered through CDC. Vaccination providers receive vaccines from CDC’s centralized distributor or directly from a vaccine manufacturer. Three vaccines are authorized and recommended to prevent COVID-19 in the United States. Other COVID-19 vaccine candidates are in development, and clinical trials are being conducted at the same time as large-scale manufacturing. The implementation of COVID-19 vaccine distribution involved detailed planning focusing on every step of the process including:

  • Establishing and testing logistical plans with manufacturers and commercial partners that are part of CDC’s centralized COVID-19 vaccine delivery system
  • Coordinating the distribution of vaccines and needed supplies from centralized locations
  • Developing processes for ordering additional doses of the vaccine after the first supply has been shipped
  • Receiving, storing, and handling vaccines properly at very specific temperatures
  • Deciding who should receive a vaccine first, based on national recommendations, if there are not enough doses of the vaccine for everyone
  • Giving the vaccines safely during an ongoing pandemic
  • Reporting on vaccine inventory, administration, and safety using a variety of new and enhanced data systems
  • Expanding safety surveillance through new systems and additional information sources, as well as scaling up existing safety monitoring systems
  • Developing plans to assess vaccine effectiveness, which means how well the vaccines protect against COVID-19 under real-life conditions
  • Making sure the public, healthcare providers, state and local health departments and others receive timely, credible, clear communication about all aspects of the vaccination program
A safe and effective COVID-19 vaccine is a critical component of the U.S. strategy to reduce COVID-19-related illnesses, hospitalizations, and deaths. The U.S. government’s goal is to have enough COVID-19 vaccine doses for all people in the United States who choose to be vaccinated.

On April 19, 2021, as COVID-19 vaccines became more widely accessible, vaccine eligibility expanded to everyone in the U.S. aged 16 years and older. Learn more, HERE.

In May, 2021, the CDC provided some updated information for persons who are fully vaccinated. If you’ve been fully vaccinated:

  • You can resume activities that you did prior to the pandemic.
  • You can resume activities without wearing a mask or staying 6 feet apart, except where required by federal, state, local, tribal, or territorial laws, rules, and regulations, including local business and workplace guidance.
  • If you travel in the United States, you do not need to get tested before or after travel or self-quarantine after travel.
  • You need to pay close attention to the situation at your international destination before traveling outside the United States.
  • If you’ve been around someone who has COVID-19, you do not need to stay away from others or get tested unless you have symptoms.

View more FAQs on what to expect after you've been vaccinated, HERE.

While experts learn more about the protection that COVID-19 vaccines provide under real-life conditions, it will be important for everyone to continue using all the tools available to help stop this pandemic. To protect yourself and others, follow these recommendations:
  • Wear a mask over your nose and mouth
  • Stay at least 6 feet away from others
  • Avoid crowds
  • Avoid poorly ventilated spaces
  • Wash your hands often

Together, COVID-19 vaccination and following CDC’s health and safety recommendations will offer the best protection from getting and spreading COVID-19.

If you are a healthcare provider within Ada, Boise, Elmore and Valley Counties that is not enrolled to give vaccine, please call the CDH Call Center to have your practice added to a list for vaccine coordination. 208-321-2222 Open Monday through Friday from 8:30 am to 4:30 pm

IDAHO-SPECIFIC RESOURCES


FEDERAL/OTHER RESOURCES


All CDH News Releases can be found on our News webpage at https://www.cdh.idaho.gov/news

All IDHW News Releases can be found on their News webpage at https://healthandwelfare.idaho.gov/news